Progetti ed attività realizzati con InMed Pharmaceutical Inc.

• Light-damaged human ARPE-19 cells and rats as in vitro and in vivo models of retinal degeneration to evaluate neuroprotective effects of cannabinoids
  (Responsabile: Prof. Mauro Maccarrone)